Hypoxia-inducible factor-2α regulates Fas-mediated chondrocyte apoptosis during osteoarthritic cartilage destruction by Ryu, J-H et al.
Hypoxia-inducible factor-2a regulates Fas-mediated
chondrocyte apoptosis during osteoarthritic
cartilage destruction
J-H Ryu
1, Y Shin
1, YH Huh
1, S Yang
1, C-H Chun
2 and J-S Chun*
,1
Apoptosis of articular chondrocytes is associated with the pathogenesis of osteoarthritis (OA). Recently, we demonstrated that
hypoxia-inducible factor (HIF)-2a, encoded by Epas1, causes OA cartilage destruction by regulating the expression of various
matrix-degrading enzymes. Here, we investigated the involvement of HIF-2a in chondrocyte apoptosis and OA cartilage
destruction. HIF-2a levels in human and mouse OA chondrocytes were markedly elevated in association with increased
apoptosis of articular chondrocytes. Overexpression or knockdown of HIF-2a alone did not cause chondrocyte apoptosis.
However, HIF-2a expression markedly increased chondrocyte apoptosis in the presence of an agonistic anti-Fas (CD95)
antibody. HIF-2a enhanced Fas expression and potentiated downstream signaling pathways, increasing the activity of initiator
and executioner caspases. Overexpression of HIF-2a in mouse cartilage tissue, either by intra-articular injection of Epas1
adenovirus (Ad-Epas1) or in the context of chondrocyte-speciﬁc Epas1 transgenic mice, increased chondrocyte apoptosis and
cartilage destruction. In contrast, chondrocyte-speciﬁc knockout of Epas1 in mice suppressed DMM (destabilization of the
medial meniscus)-induced chondrocyte apoptosis and inhibited OA cartilage destruction. Moreover, Fas-deﬁcient mice
exhibited diminished chondrocyte apoptosis and OA cartilage destruction in response to Ad-Epas1 injection or DMM surgery.
Taken together, our results demonstrate that HIF-2a potentiates Fas-mediated chondrocyte apoptosis, which is associated with
OA cartilage destruction.
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Osteoarthritis (OA) is a degenerative disease characterized
by destruction of articular cartilage. The chondrocyte is a
unique cell type in articular cartilage that is responsible for
cartilage homeostasis and OA pathogenesis. A variety of
potential OA-causing mechanisms have been proposed,
including those involving biophysical inﬂuences and biochem-
ical factors.
1,2 OA pathogenesis is associated with inﬂam-
matory responses, a reduced ability of chondrocytes to
produce extracellular matrix, and degradation of extracellular
matrix molecules by catabolic matrix-degrading enzymes.
1,2
Apoptosis of chondrocytes and the consequent reduction
in tissue cellularity are also involved in the pathogenesis
of OA.
3,4 Increased apoptosis of chondrocytes is correlated
with the severity of human OA cartilage damage.
5,6 Apoptotic
chondrocytes are found more frequently in cartilage lesions
than in non-lesional areas,
7 and cartilage regions contain-
ing apoptotic chondrocytes show proteoglycan depletion.
8
However, the precise functional relationship between OA
and chondrocyte apoptosis is not yet clearly understood.
Chondrocytes undergo apoptosis in response to a number
of stimuli, including serum starvation, Fas ligand (FasL) or
anti-Fas antibody, and nitric oxide donors.
3,4 Fas (CD95),
a member of the tumor necrosis factor receptor family, is a
death domain-containing receptor that activates apoptosis
signaling. Binding of FasL or agonistic anti-Fas antibody to
the Fas receptor triggers apoptotic signals.
3,4 Although the
role of Fas in chondrocyte apoptosis is controversial,
9 many
linesofevidencesupportsuchanassociation.
3,4Forinstance,
Fas expression is elevated in OA cartilage compared with
normal cartilage.
10,11 In human cartilage, Fas expression is
higher in close proximity to OA lesions than in regions distal
to the lesion.
7 Fas levels are also reported to be higher
in aged cartilage, and are correlated with the decreased
cellularity in rabbit articular cartilage during aging.
12,13
Additionally, a signiﬁcant amount of soluble FasL is found
in the synovial ﬂuid of OA patients,
14 although it is the
membrane-bound form of Fas that is associated with
apoptotic cell death. Collectively, these observations suggest
that Fas and its ligand are physiologically involved in
chondrocyte apoptosis.
Recently, we demonstrated that the transcription factor
hypoxia-inducible factor (HIF)-2a, encoded by Epas1,i sa
catabolic regulator of cartilage destruction that acts by
regulating the expression of various catabolic factors, includ-
ing matrix-degrading enzymes and inﬂammation mediators.
15
In these previous studies, we found that HIF-2a expression
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www.nature.com/cddwas upregulated by pro-inﬂammatory cytokines, such as
interleukin-1b (IL1b). Its expression was also markedly
increased in human and mouse OA cartilage. Moreover,
intra-articular injection of an Epas1-expressing adenovirus
(Ad-Epas1) triggered articular cartilage destruction in mice
and rabbits. Chondrocyte-speciﬁc Epas1 transgenic (TG)
mice displayed spontaneous cartilage destruction, whereas
Epas1 knockdown in mice (Epas1
þ/–) suppressed cartilage
destruction caused by destabilization of the medial meniscus
(DMM).
15 Although it is evident that HIF-2a is a catabolic
regulator of OA cartilage destruction, it is not known whether
HIF-2a regulates chondrocyte apoptosis in OA cartilage.
Therefore, we investigated the function of HIF-2a in chon-
drocyte apoptosis and evaluated its link to cartilage destruc-
tion. For this purpose, we ﬁrst examined the role of HIF-2a in
theapoptosisofprimaryculturedmousearticularchondrocyte
caused by anti-Fas antibody, which mimics FasL. As this
in vitro system may not represent the in vivo situation, we
evaluated HIF-2a function in Fas-induced chondrocyte apop-
tosis, and its possible link to OA cartilage destruction in vivo
using human OA cartilage and various mouse models of OA
cartilage, namely STR/ort, DMM surgery, Ad-Epas1 injection,
and chondrocyte-speciﬁc Epas1 TG mice. We additionally
used HIF-2a- and Fas-deﬁcient mouse models. Here we
report that HIF-2a potentiates Fas-mediated chondrocyte
apoptosis by upregulating Fas expression and amplifying
Fas-induced apoptotic signaling in chondrocytes.
Results
Chondrocyte apoptosis in human and mouse OA
cartilage. We ﬁrst examined chondrocyte apoptosis in
human OA and experimental mouse OA cartilage to
determine the correlation between HIF-2a expression and
chondrocyte apoptosis during OA cartilage destruction.
Apoptosis was assayed in cartilage tissue sections using
TdT-mediated dUTP nick end-labeling (TUNEL) assays.
Cartilage destruction was evaluated by alcian blue staining.
TUNEL assays revealed a signiﬁcant increase in the number
of apoptotic chondrocytes in association with increased HIF-
2a expression in OA-affected (damaged) human cartilage
compared with normal and undamaged regions of OA
cartilage (Figure 1a). Chondrocyte apoptosis was also
examined in STR/ort mice, which are genetically
predisposed to develop OA-like lesions in the medial tibial
cartilage.
16 STR/ort mice at 28 weeks of age showed
increased HIF-2a expression and cartilage destruction
compared with CBA control mice. OA cartilage in STR/ort
mice also showed a marked increase in the number of
TUNEL-positive apoptotic chondrocytes (Figure 1b). Finally,
we induced cartilage destruction in mice using the DMM
surgical model.
15,17 Compared with a sham operation, DMM
surgery increased HIF-2a expression and articular cartilage
damage in association with an increase in chondrocyte
apoptosis (Figure 1c). Thus, all examined OA cartilage
showed increased HIF-2a expression and chondrocyte
apoptosis, suggesting a possible association between
HIF-2a expression and chondrocyte apoptosis.
HIF-2a stimulates anti-Fas antibody-induced apoptosis
of articular chondrocytes. Next, we examined the role
of HIF-2a in apoptosis using primary cultures of mouse
articular chondrocytes. Neither overexpression of HIF-2a
by Ad-Epas1 nor stimulation with IL1b caused chondrocyte
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Figure 1 Chondrocyte apoptosis in human and mouse OA cartilage. (a) Sulfate proteoglycan and HIF-2a protein were detected by alcian blue and
immunohistochemical staining, respectively, in normal cartilage, undamaged regions of OA cartilage, and OA-affected (damaged) human cartilage regions. Apoptotic
chondrocyteswereidentiﬁedandquantiﬁedbyTUNELstaining(n47).(b)Cartilagedestructionin28-week-oldSTR/ortmiceandcontrolCBAmicewasvisualizedbysafranin
O staining. HIF-2a protein was detected by immunostaining. Apoptotic chondrocytes were detected and quantiﬁed by TUNEL assay (n46). (c) Cartilage destruction was
determined by safranin O staining of knee joint cartilage after sham operation or DMM surgery. HIF-2a was detected by immunostaining. Apoptotic chondrocytes were
detected and quantiﬁed by TUNEL assay (n410). Values for apoptotic cells are presented as means±S.E.Ms. *Po0.01 and **Po0.001. Scale bar: 50mm
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Cell Death and Differentiationapoptosis. However, stimulation of the Fas receptor with
an agonistic anti-Fas antibody caused chondrocyte apop-
tosis (Figure 2a and Supplementary Figure 1a). Mouse
articular chondrocytes expressed Fas on the cell surface, as
determined by ﬂuorescence-activated cell sorting (FACS)
analysis (Figure 2b) and confocal microscopy (Supple-
mentary Figure 2). Anti-Fas antibody-induced chondrocyte
apoptosis was concentration-dependent: a low concentration
of antibody (0.1mg/ml) did not cause signiﬁcant apoptosis,
but higher concentrations (0.5 and 1mg/ml) did (Figure 2c
and Supplementary Figure 1b). Although ectopic expression
of HIF-2a alone did not cause chondrocyte apoptosis,
overexpression of HIF-2a in the presence of a low concen-
tration (0.1mg/ml) of anti-Fas antibody caused a dramatic
increase in chondrocyte apoptosis (Figure 2d and Supple-
mentary Figure 1c). HIF-2a expression also enhanced chon-
drocyte apoptosis at high antibody concentrations (0.5mg/ml
and 1mg/ml; Figure 2e and Supplementary Figure 1d). Both
the apoptotic death of chondrocytes caused by anti-Fas
antibody and its potentiation by HIF-2a expression were also
conﬁrmed by DNA fragmentation assays (Supplementary
Figure 3a). Counts of apoptotic cells by FACS analysis with
ﬂuorescein isothiocyanate (FITC)-conjugated annexin V, or
propidium iodide staining showed similar results (Supple-
mentary Figures 3b and c). Treatment of chondrocytes
with anti-Fas antibody did not affect HIF-2a expression, and
knockdown of Epas1 expression using speciﬁc small inter-
fering RNA (siRNA) did not affect anti-Fas antibody-induced
chondrocyte apoptosis (Supplementary Figure 4).
Similar to the effects of HIF-2a expression, IL1b treatment
enhanced chondrocyte apoptosis in the presence of a low
concentration (0.1mg/ml) of anti-Fas antibody (Figure 3a and
Supplementary Figure 5a). The stimulatory effects of IL1b
on chondrocyte apoptosis were statistically signiﬁcant at
concentrations as low as 10pg/ml, a concentration within
the range of that found in the synovial ﬂuid of human OA
patients (o20pg/ml).
18 IL1b additionally enhanced chondrocyte
apoptosis at high concentrations of anti-Fas antibody
(Figure 3b). We have previously shown that IL1b promotes
expression of HIF-2a, which, in turn, mediates IL1b-induced
expression of catabolic factors in chondrocytes.
15 We there-
fore examined whether the stimulatory effects of IL1b on
chondrocyte apoptosis required HIF-2a expression. siRNA-
mediated Epas1 knockdown signiﬁcantly blocked the stimu-
latory effects of IL1b on chondrocyte apoptosis in the
presence of anti-Fas antibody (Figure 3c and Supplementary
Figure 5b). Therefore, HIF-2a appears to contribute to the
induction and enhancement of anti-Fas antibody-dependent
chondrocyte apoptosis by IL1b.
HIF-2a regulates chondrocyte apoptosis in OA
cartilage. To validate the role of HIF-2a in chondrocyte
apoptosis during OA cartilage destruction in vivo, we over-
expressed HIF-2a in cartilage tissue by injecting Ad-Epas1
into mouse knee joints. Consistent with our previous
results,
15 Ad-Epas1 injection caused HIF-2a overexpres-
sion in association with severe cartilage destruction. Under
these conditions, chondrocyte apoptosis was signiﬁcantly
increased in OA cartilage (Figure 4a). Cartilage destruction
and a signiﬁcant increase in chondrocyte apoptosis were
also observed in aged (45-week-old) chondrocyte-speciﬁc
Epas1 TG mice (Figure 4b), which exhibit spontaneous OA
cartilage destruction.
15 The function of HIF-2a in chondrocyte
apoptosis in vivo was further characterized using HIF-2a
knockout (KO) mice. As homozygous HIF-2a KO mice
(Epas1
 / ) die in utero, we used heterozygotes (Epas1
þ/ )
for DMM-induced experimental OA. Consistent with our
previous results,
15 DMM caused cartilage destruction in
association with an increase in HIF-2a expression in wild-
type (WT) mice, whereas both were signiﬁcantly attenuated
in Epas1
þ/  mice (Figure 4c). DMM surgery also caused a
signiﬁcant increase in chondrocyte apoptosis in WT mice that
paralleled the HIF-2a expression pattern; this too was
blocked in Epas1
þ/  mice (Figure 4d).
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Figure 2 HIF-2a stimulates anti-Fas antibody-induced chondrocytes apoptosis. (a) Primary cultured mouse articular chondrocytes were untreated, treated with IL1b
(2ng/ml), or infected at a multiplicity of infection (MOI) of 400 with empty Ad (Mock) or Ad-Epas1 for 24h. Alternatively, cells were treated with anti-Fas antibody (1mg/ml) for
6h. Apoptotic chondrocytes were quantiﬁed by FACS analysis. (b) Surface expression of Fas in articular chondrocytes was determined by FACS analysis. (c) Articular
chondrocytes weretreatedwith IgG (1mg/ml) or anti-Fasantibodyfor 6h, andapoptoticchondrocyteswere quantiﬁedby FACSanalysis. (d)Chondrocyteswereinfectedwith
empty Ad (Mock; 400 MOI) or Ad-Epas1 (at the indicated MOIs) for 24h. The cells were incubated with anti-Fas antibody for an additional 6h, and apoptotic chondrocytes
werequantiﬁed.(e)ChondrocyteswereinfectedwithemptyAd(Mock)orAd-Epas1atanMOIof400for24h.ThecellsweretreatedwithIgG(1mg/ml)oranti-Fasantibodyfor
6h, and apoptotic chondrocytes were quantiﬁed. Values in a, c, d, and e are presented as means±S.E.Ms. (n410). *Po0.001 and **Po0.0005
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Cell Death and DifferentiationThe role of HIF-2a in chondrocyte apoptosis was further
examined using chondrocyte-speciﬁc Epas1 conditional KO
(CKO) mice (Epas1
ﬂ/ﬂ;Col2a1-Cre). Similar to the results
obtained in Epas1
þ/  mice, CKO of Epas1 exerted a
protective effect against the cartilage destruction induced
by DMM surgery, as determined by safranin O staining and
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Figure3 HIF-2amediatesIL1b-inducedstimulationofchondrocyteapoptosis.(a)MousearticularchondrocytesweretreatedwiththeindicatedamountofIL1bfor24h.
The cells were incubated with 0.1mg/ml of IgG or anti-Fas antibody for an additional 6h, and apoptotic chondrocytes were quantiﬁed. (b) Chondrocytes were untreated or
treated with 2ng/ml of IL1b for 24h. The cells were then incubated with 1mg/ml of IgG or anti-Fas antibody for an additional 6h, and apoptotic chondrocytes were quantiﬁed.
(c) Chondrocytes were transfected with 100nM control siRNA (C-siRNA) or the indicated amounts (nM) of Epas1 siRNA. Following incubation for 12h, the cells were treated
with IL1b for 24h and exposed to 0.1mg/ml of IgG or anti-Fas antibody for an additional 6h; apoptotic chondrocytes were quantiﬁed by FACS analysis. Values in a–c are
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Figure 4 HIF-2a regulates chondrocyte apoptosis in OA cartilage. (a) Empty Ad (Mock) or Ad-Epas1 virus was injected into knee joints of C57BL/6 mice.
After 2 weeks, mice were killed and cartilage sections were used for safranin O staining, HIF-2a detection, and TUNEL assay. Cartilage destruction was scored
by Mankin’s method and apoptotic chondrocytes were quantiﬁed by TUNEL assay (n¼10). (b) Safranin O staining, immunohistochemical detection of HIF-2a, and TUNEL
assay of cartilage sections from 45-week-old Epas1 TG or WT mice. Cartilage destruction was scored by Mankin’s method and apoptotic chondrocytes were quantiﬁed
by TUNEL assay (n¼6). (c) Safranin O staining of cartilage sections from sham- and DMM-operated WT and Epas1
þ/  mice. Cartilage destruction was scored using
Mankin’s method (n¼10). (d) HIF-2a and apoptotic chondrocytes were detected in WT and Epas1
þ/  mice. Quantitation of apoptotic cells is shown in the right panel
(n¼8). Values for Mankin scores and apoptotic cells are presented as means±S.E.Ms. of the indicated n’s. *Po0.01 and **Po0.0001. Scale bar: 50mm
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Cell Death and Differentiationscoring by Mankin’s method (Figure 5a). As expected, DMM
surgery did not induce HIF-2a expression in HIF-2a CKO
mice, and chondrocyte apoptosis was signiﬁcantly inhibited
in these mice (Figure 5b). The role of HIF-2a in chondrocyte
apoptosis was also examined using primary cultures of
chondrocytes isolated from WT and HIF-2a CKO mice.
Ectopic expression of HIF-2a enhanced anti-Fas antibody-
induced apoptosis, whereas deletion of HIF-2a in chondro-
cytes did not affect anti-Fas antibody-induced apoptosis
(Figure 5c). However, the enhancement of anti-Fas anti-
body-induced apoptosis by IL1b stimulation was signi-
ﬁcantly inhibited by HIF-2a deletion (Figure 5d), conﬁrming
that IL1b-induced chondrocyte apoptosis is dependent, at
least in part, on Epas1 expression.
HIF-2a stimulates chondrocyte apoptosis by upregu-
lating Fas expression and amplifying downstream
signaling. To elucidate the mechanisms of HIF-2a stimu-
lation of Fas-mediated chondrocyte apoptosis, we inves-
tigated the expression levels of Fas and Fasl in articular
chondrocytes. Endogenous Fasl expression levels were
low and were not changed by IL1b treatment or Ad-Epas1
infection (data not shown). However, Ad-Epas1 or IL1b
markedly enhanced Fas expression, as detected by reverse
transcription-PCR (RT-PCR; Supplementary Figure 6a) and
quantiﬁed by quantitative RT-PCR (qRT-PCR; Figure 6a).
FACS analyses additionally revealed enhanced surface
expression of Fas in articular chondrocytes following Ad-
Epas1 infection or IL1b treatment (Figure 6b). The promoter
of mouse Fas contains three HIF-2a binding sites ( CGTG )
at positions  736,  108 and  56, and chromatin immuno-
precipitation assays indicated direct binding of HIF-2a to
the proximal two binding sites (Figure 6c). The signiﬁcance of
Fas upregulation in chondrocyte apoptosis was validated by
inhibiting Fas expression with speciﬁc siRNA. Knockdown
of Fas signiﬁcantly inhibited chondrocyte apoptosis caused
by Ad-Epas1 infection or IL1b treatment (Figure 6d). Finally,
we examined Fas expression in chondrocytes of OA cartilage
to examine the possible association of Fas upregulation
with cartilage destruction. Fas expression was markedly
increased in OA cartilage, both in the spontaneous OA
cartilage of STR/ort mice and in Ad-Epas1-induced OA
cartilage. DMM surgery also increased Fas expression, an
effect that was blunted in chondrocyte-speciﬁc Epas1 CKO
mice (Figure 6e and Supplementary Figures 6b and c).
As the increase in Fas expression induced by HIF-2a
suggests ampliﬁcation of apoptotic signals, we next examined
Fas downstream signaling. Fas transduces apoptotic signals
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Figure 5 Chondrocyte-speciﬁc CKO of Epas1 suppresses chondrocyte apoptosis and OA cartilage destruction. (a and b) Safranin O staining from control (Epas1
ﬂ/ﬂ)
and CKO mice following DMM surgery or sham operation. Scale bar: 100mm. Cartilage destruction was scored by Mankin’s method. Values are presented as
means±S.E.Ms. (n¼12) (a). HIF-2a and apoptotic chondrocytes were detected by immunohistochemical staining and TUNEL assay, respectively. Scale bar: 30mm.
Apoptotic cells were quantiﬁed by FACS analysis. Values are presented as means±S.E.Ms. (n¼6) (b). (c and d) Primary cultures of articular chondrocytes isolated from
Epas1 CKO mice and control Epas1
ﬂ/ﬂ mice were treated with anti-Fas antibody for 6h. Apoptotic cells were visualized by TUNEL assay and quantiﬁed by FACS analysis.
Valuesarepresentedasmeans±S.E.Ms.(n¼8)(c).Articularchondrocytesweretreatedwith2ng/mlofIL1bfor24hand0.1mg/mlofanti-Fasantibodyforanadditional6h.
Apoptotic cells were visualized by TUNEL assay and quantiﬁed by FACS analysis. Values are presented as means±S.E.Ms. (n¼6) (d). *Po0.005 and **Po0.0005
HIF-2a and chondrocyte apoptosis
J-H Ryu et al
444
Cell Death and Differentiationby activating an initiator caspase (e.g. caspase-8), which in
turn activates an executioner caspase (e.g. caspase-3),
followed by stimulation of a proteolytic cascade.
19 Anti-Fas
antibody slightly, but signiﬁcantly, activated caspase-8 activ-
ity, an effect that was dramatically increased by Ad-Epas1
infection or IL1b treatment (Figure 7a). Anti-Fas anti-
body more markedly activated caspase-3 than caspase-8.
Caspase-3 activity was also markedly increased byAd-Epas1
infection or IL1b treatment in the presence of anti-Fas
antibody (Figure 7b). Consistent with this, immunoﬂuores-
cence microscopy (Supplementary Figure 7) and western blot
analyses (Figure 7c) revealed that Ad-Epas1 infection or IL1b
treatment increased cleavage of caspase-8, caspase-3, and
poly (ADP-ribose) polymerase (PARP). Taken together, our
results indicate that HIF-2a stimulates anti-Fas antibody-
induced apoptosis through upregulation of Fas and ampliﬁca-
tion of downstream signaling.
Fas deﬁciency in mice inhibits chondrocyte apoptosis
and cartilage destruction. Next, we examined the
functional relevance of HIF-2a-mediated Fas upregulation
in chondrocyte apoptosis and the functional consequence of
chondrocyte apoptosis in OA pathogenesis in vivo.T od o
this, we used the C57BL/6-Lpr/Lpr mouse, which is a
Fas-deﬁcient mouse strain.
20 The increase in chondrocyte
apoptosis induced by Ad-Epas1 infection in control mice
(C57BL/6) was signiﬁcantly reduced in Fas-deﬁcient C57BL/
6-Lpr/Lpr mice (Figure 8a and Supplementary Figure 8).
Chondrocyte apoptosis caused by DMM surgery was also
signiﬁcantly reduced in Fas-deﬁcient mice (Figure 8b and
Supplementary Figure 8). These results indicate that Fas
signaling has an important role in the in vivo chondrocyte
apoptosis that takes place during OA cartilage destruction
caused by DMM surgery or Ad-Epas1 infection. Finally, the
role of Fas in chondrocyte apoptosis was validated using
primary cultures of chondrocytes isolated from control and
Fas-deﬁcient mice. As expected, anti-Fas antibody-induced
chondrocyte apoptosis and the stimulatory effects of Ad-
Epas1 or IL1b were completely abolished in Fas-deﬁcient
chondrocytes (Figure 8c). Furthermore, cartilage destruction
induced by Ad-Epas1 infection or DMM surgery was signi-
ﬁcantly inhibited in C57BL/6-Lpr/Lpr mice, as determined by
Makin scores (Figures 8a and b), supporting a functional link
between chondrocyte apoptosis and OA cartilage destruction.
Discussion
Here, we demonstrated that HIF-2a potentiates Fas-mediated
chondrocyte apoptosis, which, in turn, is associated with OA
cartilage destruction. Although overexpression or knockdown
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Figure 6 HIF-2a increases Fas expression in chondrocytes and OA cartilage. (a) Chondrocytes were infected with empty Ad (Mock; 400 multiplicity of infection (MOI))
or Ad-Epas1 (at the indicated MOIs) for 24h (left) or treated with IL1b for 24h (right). Epas1 and Fas transcript levels were quantiﬁed by qRT-PCR (n¼6). (b) Surface
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Cell Death and Differentiationof HIF-2a alone did not modulate chondrocyte apoptosis,
HIF-2a markedly potentiated Fas-mediated apoptosis, an
action that reﬂected upregulation of Fas expression and
the consequent ampliﬁcation of apoptotic signaling (see
Figure8d).WealsodemonstratedthatHIF-2aoverexpression
in mouse cartilage increased chondrocyte apoptosis and
cartilage destruction, whereas Epas1 KO mice showed a
reduction in both chondrocyte apoptosis and cartilage
destruction.Furthermore,micelackingtheFasgeneexhibited
reduced chondrocyte apoptosis and OA cartilage destruction.
Therefore, our results provide evidence for a link between
chondrocyte apoptosis and cartilage destruction by HIF-2a.
The results of in vitro experiments using articular chondro-
cytes indicate that HIF-2a causes chondrocyte apoptosis at
low concentrations of anti-Fas antibody and markedly
enhances apoptosis at high antibody concentrations. The
induction and enhancement of chondrocyte apoptosis by
HIF-2a appears to be attributable to its capacity to increase
Fas expression. Indeed, the Fas gene is a direct target
of HIF-2a in mouse articular chondrocytes. The signiﬁ-
cance of Fas upregulation was directly demonstrated by the
observation that knockdown of Fas expression inhibited the
potentiation of chondrocyte apoptosis by Ad-Epas1 infection
or IL1b treatment. Ligand-stimulated Fas receptors initiate
apoptotic signaling by activating an initiator caspase, such
as caspase-8, which is activated by self-cleavage. The acti-
vated caspase-8, in turn, stimulates an executioner caspase,
such as caspase-3, to activate a proteolysis cascade.
19
Consistent with this, HIF-2a potentiated the activation of
initiator caspase-8 and effector caspase-3, as well as
cleavageofthecaspase-3targetprotein,PARP.Wetherefore
conclude that HIF-2a potentiates chondrocyte apoptosis
through upregulation of Fas and ampliﬁcation of downstream
apoptotic signaling.
We have previously shown that HIF-2a expression is
stimulated by IL1b in articular chondrocytes.
15 In the current
study, we observed that anti-Fas antibody-induced chondro-
cyte apoptosis was signiﬁcantly enhanced by IL1b treatment.
The stimulatory effects of IL1b on chondrocyte apoptosis
appear to be mediated by HIF-2a expression because
knockdown of Epas1 inhibited IL1b-induced enhancement
of apoptosis. However, although IL1b-enhanced apoptosis
was markedly inhibited in HIF-2a KO chondrocytes, IL1b
still enhanced anti-Fas antibody-induced chondrocyte apop-
tosis. This indicates the existence of HIF-2a-independent
apoptosis-inducing mechanisms, although these were not
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Cell Death and Differentiationexplored in this study. The effect of IL1b on chondrocyte
apoptosisisamatterofcontroversyandappearstodependon
experimental conditions. Similar to our results, it has been
shown that IL1b induces apoptosis of rat
21 and human
22 OA
chondrocytes. In contrast, Ku ¨hn et al.
23 have reported that
IL1b protects against anti-Fas antibody-induced apoptosis of
human chondrocytes. Although additional studies will be
required to resolve these discrepancies, they could reﬂect
differences in experimental conditions. We used passage 0
primary cultured mouse articular chondrocytes, whereas
Ku ¨hn et al. used second-passage human OA chondrocytes.
Serial passage in culture is known to cause a loss of the
differentiated chondrocyte phenotype,
24 and such a change
in differentiation status could modulate IL1b effects. Another
possible explanation for the discrepant ﬁndings is a differ-
ence in IL1b treatment conditions. Ku ¨hn et al.
23 co-treated
chondrocyte with anti-Fas antibody and ILb for 14h, whereas
we pretreated chondrocytes with IL1b or Ad-Epas1 for 24h
before treatment with anti-Fas antibody. Pretreatment with
IL1b or HIF-2a overexpression could alter the gene expres-
sion proﬁle in chondrocytes, leading to a more apoptosis-
promoting state. Indeed, we observed that IL1b and HIF-2a
enhanced Fas expression in chondrocytes. Nevertheless, our
current results clearly indicate that pretreatment with IL1b,
and HIF-2a overexpression markedly enhanced chondrocyte
apoptosis, suggesting a contribution of HIF-2a to OA cartilage
destruction.
The signiﬁcance of HIF-2a in chondrocyte apoptosis in vivo
wassuggestedbytheobservationsthatHIF-2aandFaslevels
were markedly increased in human OA cartilage and various
mouse models of OA cartilage. Consistent with this, a number
ofstudieshaveindicatedthatFasexpressionisupregulatedin
OA chondrocytes.Faslevelsare reportedto behigherin aged
cartilage, and are correlated with the decrease in cellularity in
rabbit articular cartilage during aging.
12,13 Upregulation ofFas
is also observed in rabbit chondrocytes after OA induction.
10
In human articular cartilage, expression of Fas is increased in
OA chondrocytes,
11 and Fas expression is higher in close
proximity to OA lesions than in regions distal to the lesion.
7
In the current study, we found that FasL was expressed in
chondrocytes, although the expression levels were low. Other
studies have also reported expression of FasL in chondro-
cytes. For instance, mRNA levels of FasL are higher in aged
cartilage, and FasL expression is increased in rabbit OA
cartilage.
10,12 FasL upregulation is also observed in human
OA cartilage and chondrocytes.
11 In these previous studies,
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Figure 8 Fas-deﬁcientmiceexhibitmarkedlyinhibited chondrocyteapoptosisandcartilage destruction. (a)Apoptoticchondrocytes werequantiﬁedbyTUNELassayin
Fas-deﬁcient C57BL/6-Lpr/Lpr mice (Lpr/Lpr) and C57BL/6 control mice (B6), after DMM and sham operations (n¼9). Cartilage destruction was visualized by safranin O
staining and quantiﬁed by Mankin’s method (n¼9). (b) Control (B6) and Lpr/Lpr mice were injected with empty Ad (Mock) or Ad-Epas1, and apoptotic chondrocytes were
quantiﬁed(n¼7).CartilagewasstainedwithsafraninO,anddestructionwasscoredbyMakin’smethod(n¼7).(c)Chondrocytesisolatedfromcontrol(B6)andLpr/Lprmice
wereuntreated, treatedwith IL1b (nM), orinfectedwith emptyAd (Mock)orAd-Epas1at an MOI (multiplicityof infection)of 400. Thecellsweretreatedwith normal IgG orthe
indicated concentrations of anti-Fas antibody, and apoptotic cells were quantiﬁed by FACS analysis (n¼8). (d) Schematic diagram depicting HIF-2a regulation of
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Cell Death and Differentiationhowever, it was not determined whether the increase in FasL
mRNA levels resulted in an increase in the expression of
membrane-bound FasL, which is linked to the apoptotic
pathway. Our current results indicate that HIF-2a upregulates
Fas expression without modulating FasL expression in
chondrocytes. Therefore, we speculate that increased Fas
expression potentiates death signaling in chondrocytes, even
in the context of the low FasL levels in chondrocytes.
However, this interpretation should be considered with care.
Although upregulation of Fas on chondrocytes makes the
cells a potential target for Fas/FasL-induced apoptosis, it
remains to be clariﬁed whether Fas upregulation is sufﬁcient
to cause chondrocyte apoptosis in the presence of low FasL
levels. Indeed, aggregation of pre-assembled Fas trimers by
FasL trimers or antagonistic Abs has been shown to trigger
apoptosis in vivo and in vitro, respectively.
3,4 Additionally, the
dense nature of cartilage matrix and the existence of
chondrocyte as single cells in cartilage tissue may hinder
the free movement of FasL on the cell membrane, thus
interfering with receptor engagement on chondrocytes.
However, changes in cartilage stiffness during OA progres-
sion,
25 and aggregation of chondrocytes in OA cartilage may
make FasL movement and receptor engagement possible.
Consistent with the upregulation of HIF-2a and Fas in OA
cartilage, Epas1
þ/  mice and Epas1 CKO mice showed a
reduction in both chondrocyte apoptosis and cartilage
destruction. The functional relevance of HIF-2a-mediated
Fas upregulation in chondrocyte apoptosis and the functional
consequence of chondrocyte apoptosis in OA pathogenesis
were explored in vivo using C57BL/6-Lpr/Lpr mice, which lack
the Fas gene.
20 Mice of the MRL strain with the lymphopro-
liferation (Lpr) mutation spontaneously develop a complex,
rheumatoid arthritis-like immunological disease that is caused
by a mutation in the Fas gene.
20 However, other strains of
mice with the Lpr mutation, such as C57BL/6, do not develop
spontaneous arthritis.
26 Therefore, we used Lpr/Lpr mice
inbred on a C57BL/6 background (C57BL/6-Lpr/Lpr)a sa
Fas-deﬁcient mouse model. Our results indicate that a
deﬁciency of Fas inhibited in vivo chondrocyte apoptosis
upon DMM surgery or Ad-Epas1 infection. This supports our
hypothesis that induction and enhancement of chondrocyte
apoptosis is due to Fas upregulation rather than indirect
induction of apoptosis by other deleterious effects of HIF-2a
on chondrocytes, such as expression of catabolic factors.
Fas-deﬁcient mice also exhibited reduced OA cartilage
destruction upon Ad-Epas1 injection or DMM surgery. This
supports the functional signiﬁcance of chondrocyte apoptosis
in OA pathogenesis. We have previously shown that HIF-2a
regulates the expression of catabolic factors, such as matrix
metalloproteinase (MMP) 3 and MMP13,
15 which have crucial
roles in OA pathogenesis.
27,28 Therefore, our current results
suggest an essential role for HIF-2a-mediated chondrocyte
apoptosis in OA pathogenesis in addition to its role in inducing
the expression of catabolic factors, such as matrix-degrading
enzymes and inﬂammation mediators.
Materials and Methods
Animals. Male C57BL/6, Epas1 TG, Epas1
þ/ , Epas1
ﬂ/ﬂ; Col2a1-Cre, C57BL/
6-Lpr/Lpr, STR/ort, and CBA/CaCrl mice were used for experimental OA studies.
Chondrocyte-speciﬁc Epas1 TG mice were generated using the Col2a1 promoter
and enhancer.
15 Epas1
þ/  mice,
29 Epas1
ﬂ/ﬂ mice,
30 and Col2a1-Cre TG mice
31
were obtained from Jackson Laboratories (Bar Harbor, ME, USA). Epas1
ﬂ/ﬂ mice
were crossed with Col2a1-Cre TG mice to generate Epas1
ﬂ/þ; Col2a1-Cre mice.
These mice were backcrossed with Epas1
ﬂ/ﬂ mice to generate chondrocyte-speciﬁc
CKO mice (Epas1
ﬂ/ﬂ; Col2a1-Cre). Primers used for genotyping are described in
Supplementary Table 1. C57BL/6-Lpr/Lpr mice
20 were purchased from Japan SLC,
Inc. (Shizuoka, Japan); C57BL/6 mice were used as a congenic control for Lpr/Lpr
mice. Animals were maintained under pathogen-free conditions. All experiments
were approved by the Gwangju Institute of Science and Technology Animal Care
and Use Committee.
Human OA cartilage and experimental OA in mice. Normal human
knee joint cartilage was obtained from patients who experienced meniscus
problems during arthroscopic meniscectomy or meniscal repair. Human OA knee
joint cartilage was sourced from individuals who had undergone arthroplasty.
15 The
Review Board of the Wonkwang University Hospital approved the use of these
materials,andallindividualsprovidedinformed,writtenconsentbeforetheoperative
procedure. Spontaneous OA in STR/ort
16 and Epas1 TG mice was examined at 28
and 45 weeks of age, respectively. Experimental OA in mice was induced by DMM
surgery;sham-operatedmicewereusedascontrols.
15,17ExperimentalOAwasalso
induced byintra-articular injection of Ad-Epas1 (1 10
9 plaqueformingunits (PFU))
in10–12-week-oldmalemice;controlmicewereinjectedwithempty Advirus (mock
infection).
15Micewerekilled8weeksafterDMMsurgeryor2weeksafterAd-Epas1
injection for analysis of cartilage tissue.
Histological analysis and apoptosis assay. Normal and OA human
cartilage were frozen, sectioned at 6-mm thickness, and ﬁxed in paraformaldehyde.
OA cartilage damage was established based on alcian blue staining, and scored
according to the International Cartilage Repair Society grading system.
15,32 HIF-2a
protein was detected using standard immunohistochemical staining techniques.
15
Mouse cartilage tissues were ﬁxed in paraformaldehyde, decalciﬁed, embedded in
parafﬁn, and sectioned at 6-mm thickness. Cartilage destruction was evaluated by
safranin O staining and was scored according to Mankin’s method.
15,33 For HIF-2a
immunohistochemical staining, mouse cartilage tissue was scraped off with a blade
and embedded in parafﬁn after ﬁxation with paraformaldehyde, omitting the
decalciﬁcation step. HIF-2a was detected in sections (5-mm thick) using standard
immunohistochemical staining techniques.
15 Apoptosis of articular chondrocytes in
cartilage tissues was determined by TUNEL assay using a kit from Roche
Diagnostics (Mannheim, Germany). Specimens were visualized under a
ﬂuorescence microscope. The number of apoptotic chondrocytes in relation to
the total number of cells was quantiﬁed in tissue sections. More than three ﬁelds of
microscopic view in each section, and multiple sections (more than three) from at
least six different experimental animals in each experimental group were used.
Primary culture of articular chondrocytes and apoptosis
assay. Mouse articular chondrocytes were obtained from 6-day-old ICR mice,
Epas1
ﬂ/ﬂ mice, Epas1
ﬂ/ﬂ; Col2a1-Cre mice, and C57BL/6-Lpr/Lpr mice.
Chondrocytes were isolated from femoral heads, femoral condyles and tibial
plateaus of each mouse as described previously,
34 and maintained as a monolayer
inDulbecco’sModiﬁedEagleMediumcontaining10%fetalbovineserum.Apoptosis
was induced in culture day-3 chondrocytes by treating with anti-mouse Fas
antibody. Brieﬂy, chondrocytes were treated for 6h with the indicated amounts of
anti-mouse Fas antibody (BD Biosciences, Franklin Lakes, NJ, USA) in the
presence of 0.5mg/ml of recombinant protein G to enhance receptor cross-linking.
Hamster IgG2 (1mg/ml) in the presence of protein G was used as a control. The
effects of HIF-2a and IL1b were examined by treating chondrocytes with the
indicated amount of empty Ad (mock), Ad-Epas1, or IL1b (2ng/ml) for 24h. The
cells were exposed to anti-Fas antibody and protein G for an additional 6h.
ApoptoticdeathofchondrocyteswasconﬁrmedbyTUNELassay.
35Allexperiments
with each primary culture were performed in duplicate in Dulbecco’s Modiﬁed Eagle
Medium containing 0.5% fetal bovine serum. n’s indicate the number of primary
cultures. Chondrocyte apoptosis was also determined by DNA fragmentation assay
and ﬂow cytometry based on the number of cells containing fragmented DNA.
Apoptotic chondrocytes were quantiﬁed by FACS analysis using cells stained with
FITC-conjugated annexin V or propidium iodide (BD Biosciences).
35
Assay of Fas expression. mRNA levels of Fas in articular chondrocytes
were detected by RT-PCR and quantiﬁed by qRT-PCR. PCR primers and
experimental conditions are summarized in Supplementary Table 1. Cell surface
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Cell Death and DifferentiationFas expression was assessed by immunoﬂuorescence microscopy and FACS
analysis. For FACS analysis, mouse articular chondrocytes were untreated or
treated with IL1b or infected with Ad-Epas1 for 24h. The cells were harvested,
suspendedto a concentration of 1 10
6cells/ml in ice-cold PBS, and incubated for
20min at 41C with 5mg/ml of R-phycoerythrin (PE)-conjugated hamster anti-mouse
Fas antibody (clone Jo2; BD Biosciences). PE-conjugated hamster IgG2 (BD
Biosciences) was used as a control IgG. After washing twice with PBS, cells were
analyzed using a FACScan ﬂow cytometry system (EPIC XL; Beckman Coulter,
Brea, CA, USA). For immunoﬂuorescence microscopy of Fas, chondrocytes were
isolatedfromC57BL/6mice,culturedon coverslipsfor 4days,and incubatedfor 1h
at room temperature with 2mg/ml of FITC-conjugated hamster anti-mouse Fas
antibody. FITC-conjugated hamster IgG2 was used as a control (BD Biosciences).
We also used chondrocyte isolated from Fas-deﬁcient Lpr/Lpr mice as a negative
control for Fas expression. Fas expression was additionally examined by using
PE-conjugated hamster anti-mouse Fas antibody (clone Jo2) or PE-conjugated
hamster IgG2 (BD Biosciences) as a control antibody. Fas surface expression was
visualized under an Olympus FV1000 confocal laser-scanning biological microscope
(Olympus, Tokyo, Japan).
Caspase assay. Activities of caspase-3 and caspase-8 were determined using
a caspase colorimetric assay kit (R&D Systems Inc., Minneapolis, MN, USA).
Brieﬂy, chondrocyte lysates were incubated with substrate for caspase-3 (DEVD-
pNA) or caspase-8 (IETD-pNA) for 2h at 371C. The activity of each caspase was
determined by measuring absorbance at 405nm. Cleavage of caspases and PARP
was determined by immunoﬂuorescence microscopy using antibodies speciﬁc to
cleaved-forms. Both pro-forms and cleaved-forms of caspases and PARP on the
same blot were detected by western blot analysis using antibodies recognizing both
forms. Antibodies against caspase-3 (rabbit anti-human caspase-3 polyclonal;
#9662) and PARP (rabbit anti-PARP polyclonal; #9542) were obtained from Cell
Signaling Technology (Danvers, MA, USA). Rabbit anti-caspase-8 polyclonal
antibody (#AB1879) was purchased from Millipore (Temecula, CA, USA).
siRNA,RT-PCR, andqRT-PCR. Total RNA was extracted from humanand
mousecartilagetissue,andarticularchondrocytes.Formousecartilagetissue,knee
joints from control and OA cartilage were scraped with a blade to remove cartilage,
and RNA was isolated from the removed cartilage using the TRI reagent (Molecular
ResearchCenterInc.,Cincinnati,OH,USA).TheRNAwasreversetranscribed,and
the resulting cDNA was ampliﬁed by PCR. PCR primers and experimental
conditions are summarized in Supplementary Table 1. Transcript levels were
quantiﬁedby qRT-PCR.ThesiRNAsequencesthat silencedEpas1mosteffectively
were used in this study.
15 The Fas siRNA pool was purchased from Dharmacon
(Chicago, IL, USA). Non-silencing siRNA was used as a negative control.
Chondrocytes cultured for 60h were transfected for 6h with siRNA using
Lipofectamine2000(Invitrogen,Carlsbad,CA,USA),andinfectedwithAd-Epas1or
treated with IL1b.
Chromatin immunoprecipitation assays. Chromatin immunoprecipitation
assays of mouse articular chondrocytes treated with IL1b or infected with Ad-Epas1
were performed using a kit (Millipore), as described by the manufacturer. Brieﬂy, cells
were ﬁxed with 1% formaldehyde for 10min to cross-link protein and bound DNA, and
suspended in sodium dodecyl sulfate lysis buffer. After preclearing lysates with anti-
rabbitIgG,chromatinwasincubatedwith2mganti-HIF-2aantibody(NovusBiologicals,
Littleton, CO, USA). Antibody–protein–DNA complexes were isolated by precipitation
with protein A-agarose. Pellets were eluted with elution buffer (1% sodium dodecyl
sulfate and 0.1M NaHCO3), mixed with 5M NaCl, and heated for 4h at 651C.
DNA was puriﬁed using phenol extraction and ampliﬁed by PCR. The primers were
designed to allow ampliﬁcation of the three different HIF-response element-containing
regions of the Fas promoter (Supplementary Table 1).
Statistical analysis. Statistical signiﬁcance was evaluated using Student’s
t-test. Signiﬁcance was accepted at the 0.05 level of probability (Po0.05).
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